Status:
WITHDRAWN
Open-Label, Single- and Multiple-Dose Pharmacokinetic Study of Diazoxide Choline
Lead Sponsor:
Essentialis, Inc.
Conditions:
Hypertriglyceridemia
Eligibility:
All Genders
18-75 years
Phase:
PHASE1
Brief Summary
This is a single-center, randomized, open-label, single- and multiple-dose, five-treatment, two-period, four-way parallel study comparing the pharmacokinetics (PK) of Diazoxide Choline Controlled-Rele...
Eligibility Criteria
Inclusion
- Signed informed consent
- Healthy adults
- Fasting glucose ≤ 125 mg/dL and HbA1C ≤ 6.5
- Fasting triglyceride ≥150 mg/dL and ≤ 500 mg/dL
Exclusion
- Known CAD, DM, uncontrolled HTN
- Pregnancy or unable to complaint with the birth control method required
Key Trial Info
Start Date :
March 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2011
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00901823
Start Date
March 1 2011
End Date
March 1 2011
Last Update
September 1 2016
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.